VKTX · Viking Therapeutics Inc.
AI read · Neutral
The AI's read
Viking Therapeutics shares fell about 5% during a broad market pullback. The company’s obesity program and large manufacturing capacity remain intact, so this report leaves Viking's prospects unchanged.